West Bengal's Urban Development
Minister Firhad Hakim became the second minister of a state government in the country to be administered a shot of Covaxin, India's first indigenous COVID-19 vaccine candidate whose Phase III trial began here on Wednesday.
The trial, which started at the city's ICMR-National Institute of Cholera and Enteric Diseases (NICED), was inaugurated by state Governor Jagdeep Dhankhar.
"I feel I am quite lucky to be part of the trial. I am absolutely okay after taking the shot. I do not care even if I die while undertaking this trial," the 62-year-old minister told reporters.
Hakim said that he will be very happy if his contribution helps in the quest for the vaccine against the coronavirus disease.
Hakim underwent necessary check-ups to ascertain whether he was fit for the shot.
At least 1,000 volunteers will be administered the vaccine during the Phase III trial here.
Before him, Haryana's Health Minister Anil Vij was administered a dose of Covaxin last month as part of the Phase III clinical trial .
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)